Clasp Therapeutics aims to bring absolute precision to immuno-oncology by developing next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations across hard-to-treat cancers. Clasp is developing T cell engagers to match both the specific characteristics of the patient’s immune system and the specific genetics of their tumor, enabling the creation of exquisitely personalized, yet off-the-shelf, therapeutics. Built upon academic research in the labs of Bert Vogelstein and Drew Pardoll at Johns Hopkins University, Clasp is backed by prominent life sciences investors including Catalio Capital Management, Third Rock Ventures and Novo Holdings. The company was launched in March 2024 and is based in Cambridge, MA and Rockville, MD. For more information about Clasp, please visit www.clasptx.com

Clasp Therapeutics

Caribou Biosciences is a biotechnology company focused on developing CRISPR-based gene editing technologies for cellular engineering and immuno-oncology applications.

Caribou Biosciences

Kite Pharma is a biopharmaceutical company that develops innovative cancer immunotherapies using engineered autologous cell therapy.

Kite Pharma

Carisma Therapeutics is a biotechnology company focused on developing chimeric antigen receptor macrophage (CAR-M) cell therapies for solid tumors.

Carisma Therapeutics

Kojin TX is a biotechnology company that focuses on developing novel T cell therapies for cancer treatment.

Kojin TX

Genevant is a biopharmaceutical company specializing in the development of nucleic acid-based therapeutics for various diseases, including cancer.

Genevant

Gadeta is a biotechnology company focused on developing gamma delta (γδ) T cell receptor (TCR) therapeutics for the treatment of cancer.

Gadeta

EvolveImmune Therapeutics is a biotechnology company that develops novel immunotherapies for the treatment of cancer and other diseases.

EvolveImmune Therapeutics

Umoja Biopharma is a startup specializing in the development of novel immunotherapies for the treatment of cancer, leveraging innovative technologies.

Umoja Biopharma

Mogrify is a startup focused on the development of transformative cell therapies for various diseases, including cancer, using direct cellular conversion technology.

Mogrify

Clasp Therapeutics is a biotech company that aims to pioneer precision immuno-oncology using next-generation T-cell engagers with unparalleled specificity, focusing on tumor-specific antigens.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 3, 2024 5:38 AM	8f47c167
public peers	general	May 3, 2024 5:38 AM	ee75321e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 3, 2024 5:38 AM	e7b42801
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	36995d2b
crunchbase profile	general
li profile	general	May 3, 2024 5:38 AM	6e2853f1
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 3, 2024 5:38 AM	6aa44c7e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CLASPTX

Clasp Therapeutics